Aline Schmoll K, Mager T, Tse T, Alameldeen A, Zimmermann W, Zafeiriou M. Genome engineering of a neuronal specific, optogenetic, induced pluripotent stem cell line. Stem Cell Res. 2024;75:103317 pubmed publisher

Mester P, R xe4 th U, Schmid S, Amend P, Keller D, Krautbauer S, et al. Serum Insulin-like Growth Factor-Binding Protein-2 as a Prognostic Factor for COVID-19 Severity. Biomedicines. 2024;12: pubmed publisher

Kletzer J, Hecht S, Ramsauer S, Scharinger B, Kaufmann R, Kammler J, et al. A Story of PA/BSA and Biomarkers to Diagnose Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis-The Rise of IGF-BP2 and GDF-15. J Cardiovasc Dev Dis. 2023;10: pubmed publisher

Hecht S, Boxhammer E, Kaufmann R, Scharinger B, Reiter C, Kammler J, et al. CT-Diagnosed Sarcopenia and Cardiovascular Biomarkers in Patients Undergoing Transcatheter Aortic Valve Replacement: Is It Possible to Predict Muscle Loss Based on Laboratory Tests?-A Multicentric Retrospective Analysis. J Pers Med. 2022;12: pubmed publisher

Hong S, Park K, Lee Y, Lee J, Kim Y, Joo E, et al. Antibody microarray analysis of amniotic fluid proteomes in women with cervical insufficiency and short cervix, and their association with pregnancy latency length. PLoS ONE. 2022;17:e0263586 pubmed publisher

Ozen A, Kasap N, Vujkovic Cvijin I, Apps R, Cheung F, Karakoc Aydiner E, et al. Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease. Nat Immunol. 2021;22:128-139 pubmed publisher

Park Y, Woo S, Kim Y, Hong S, Lee Y, Park K. Immune and Inflammatory Proteins in Cord Blood as Predictive Biomarkers of Retinopathy of Prematurity in Preterm Infants. Invest Ophthalmol Vis Sci. 2019;60:3813-3820 pubmed publisher

Liu Y, Li F, Yang Y, Xu X, Chen J, Chen T, et al. IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma. Oncogene. 2019;38:1815-1831 pubmed publisher

Hawsawi Y, Humphries M, Wright A, Berwick A, Shires M, Al Kharobi H, et al. Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro. Oncotarget. 2016;7:32129-43 pubmed publisher

Mok C, Ding H, Kharboutli M, Mohan C. Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2016;68:1303-9 pubmed publisher

Yau S, Russo V, Clarke I, Dunshea F, Werther G, Sabin M. IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes. Int J Obes (Lond). 2015;39:770-81 pubmed publisher

Migita T, Narita T, Asaka R, Miyagi E, Nagano H, Nomura K, et al. Role of insulin-like growth factor binding protein 2 in lung adenocarcinoma: IGF-independent antiapoptotic effect via caspase-3. Am J Pathol. 2010;176:1756-66 pubmed publisher

Pitteri S, Jebailey L, Faca V, Thorpe J, Silva M, Ireton R, et al. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS ONE. 2009;4:e7916 pubmed publisher

Eiseman J, Guo J, Ramanathan R, Belani C, Solit D, Scher H, et al. Evaluation of plasma insulin-like growth factor binding protein 2 and Her-2 extracellular domain as biomarkers for 17-allylamino-17-demethoxygeldanamycin treatment of adult patients with advanced solid tumors. Clin Cancer Res. 2007;13:2121-7 pubmed